{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T07:35:21Z","timestamp":1781595321660,"version":"3.54.5"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To facilitate the accurate identification of clinical characteristics associated with myelin oligodendrocyte glycoprotein (MOG) antibody positive encephalitis in children presenting with normal brain magnetic resonance imaging (MRI) findings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>Patients hospitalized at Children\u2019s Hospital of Chongqing Medical University from January 2016 to May 2024, who were positive for MOG antibodies and exhibited encephalitis symptoms with normal brain MRI findings, were retrospectively analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 17 patients (7 males and 10 females; mean age: 9.2\u202f\u00b1\u202f2.8 years) were enrolled in the study. The most prevalent clinical symptoms were fever (17\/17), with a median duration of 15\u202fdays (IQR: 7.5\u201321\u202fdays), headaches (17\/17), mild alterations in mental status (17\/17), seizures (6\/17), vomiting (6\/17), decreased binocular vision (2\/17), and hemiplegia (1\/17). The majority of cases (15\/17) exhibited leukocytosis in peripheral blood (mean: 20.63\u202f\u00b1\u202f7.09\u202f\u00d7\u202f10<jats:sup>9<\/jats:sup>\/L) accompanied by an elevated neutrophil ratio. C-reactive protein (CRP) and procalcitonin (PCT) levels were normal in 13 patients (13\/17). Cerebrospinal fluid (CSF) leukocyte counts were elevated in all patients (median: 82\/mm<jats:sup>3<\/jats:sup>; IQR: 49\u2013155\/mm<jats:sup>3<\/jats:sup>). Six patients (6\/17) had elevated CSF protein levels (mean: 1.01\u202f\u00b1\u202f0.38\u202fg\/L). CSF glucose levels were normal across all patients. Next-generation sequencing of CSF was performed in 10 patients, all yielding negative results. All patients had a serum MOG antibodies titer of \u22651:32, and six children (6\/17) had a CSF MOG antibody titer of \u22651:32. All patients showed clinical improvement after immunotherapy. Only one patient (1\/17) experienced a relapse.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>For patients presenting with encephalitis and normal brain MRI findings, early testing for anti-MOG antibody should be considered if they exhibit the following characteristics: (1) persistent fever; (2) elevated peripheral blood white blood cell (WBC) counts, with normal or slightly elevated PCT and CRP levels; (3) mild elevation of CSF WBC counts, normal or mildly elevated protein levels, and normal CSF glucose levels; and (4) ineffectiveness of antibiotic or antiviral therapy. Encephalitis with normal brain MRI may be regarded as a potential new spectrum associated with MOG antibodies, meriting additional exploration and consideration.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2025.1537538","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T05:13:43Z","timestamp":1740546823000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Pediatric MOG antibody-positive encephalitis with normal brain magnetic resonance imaging: a new spectrum associated with MOG antibodies?"],"prefix":"10.3389","volume":"16","author":[{"given":"Yan","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiannan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/s1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international Mogad panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e790","DOI":"10.1212\/cpj.0000000000001129","article-title":"Aseptic meningitis followed by bilateral optic neuritis: an uncommon phenotype of Mogad","volume":"11","author":"Devaraj","year":"2021","journal-title":"Neurol Clin Pract"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"104939","DOI":"10.1016\/j.msard.2023.104939","article-title":"Characteristics of aseptic meningitis-like attack-an underestimated phenotype of myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"78","author":"Gu","year":"2023","journal-title":"Mult Scler Relat Disord"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/dmcn.14032","article-title":"Isolated seizures during the first episode of relapsing myelin oligodendrocyte glycoprotein antibody-associated demyelination in children","volume":"61","author":"Ramanathan","year":"2019","journal-title":"Dev Med Child Neurol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41390-024-03058-x","article-title":"Less common phenotypes of myelin oligodendrocyte glycoprotein antibody-related diseases in children deserve more attention","volume":"96","author":"Wang","year":"2024","journal-title":"Pediatr Res"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/s1474-4422(19)30488-0","article-title":"Associations of Paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study","volume":"19","author":"Armangue","year":"2020","journal-title":"Lancet Neurol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e209682","DOI":"10.1212\/wnl.0000000000209682","article-title":"Investigating the 2023 Mogad criteria in children and adults with Mog-antibody positivity within and outside attacks","volume":"103","author":"Fonseca","year":"2024","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e200323","DOI":"10.1212\/nxi.0000000000200323","article-title":"Pediatric Mog-ab-associated encephalitis: supporting early recognition and treatment","volume":"11","author":"Kim","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1177\/1352458520907900","article-title":"Frequency and characteristics of Mri-negative myelitis associated with Mog autoantibodies","volume":"27","author":"Sechi","year":"2021","journal-title":"Mult Scler"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1050688","DOI":"10.3389\/fimmu.2022.1050688","article-title":"Clinical characteristics of myelin-oligodendrocyte glycoprotein antibody-positive pediatric autoimmune encephalitis without demyelination: a case series","volume":"13","author":"Song","year":"2022","journal-title":"Front Immunol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.braindev.2021.12.009","article-title":"Children suspected of having intracranial infection with Normal brain magnetic resonance imaging may be associated with the myelin oligodendrocyte glycoprotein antibody","volume":"44","author":"Song","year":"2022","journal-title":"Brain Dev"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e209303","DOI":"10.1212\/wnl.0000000000209303","article-title":"Radiologic lag and brain Mri lesion dynamics during attacks in Mog antibody-associated disease","volume":"102","author":"Cacciaguerra","year":"2024","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1093\/cid\/cit458","article-title":"Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium","volume":"57","author":"Venkatesan","year":"2013","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"642664","DOI":"10.3389\/fneur.2021.642664","article-title":"Clinical and prognostic analysis of autoantibody-associated Cns demyelinating disorders in children in Southwest China","volume":"12","author":"Li","year":"2021","journal-title":"Front Neurol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ejpn.2020.10.007","article-title":"E.U. Paediatric Mog consortium consensus: part 4 - outcome of Paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders","volume":"29","author":"Bruijstens","year":"2020","journal-title":"Eur J Paediatr Neurol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1007\/s00415-020-10260-4","article-title":"Autoimmune cortical encephalitis in two children with anti-myelin oligodendrocyte glycoprotein (Mog) antibody","volume":"268","author":"Doig","year":"2021","journal-title":"J Neurol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/jdn.10255","article-title":"Clinical features of the first attack with Leukodystrophy-like phenotype in children with myelin oligodendrocyte glycoprotein antibody-associated disorders","volume":"83","author":"Jiang","year":"2023","journal-title":"Int J Dev Neurosci"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12974-018-1144-2","article-title":"Mog encephalomyelitis: international recommendations on diagnosis and antibody testing","volume":"15","author":"Jarius","year":"2018","journal-title":"J Neuroinflammation"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1001\/jamaneurol.2018.1814","article-title":"Association of Mog-igg Serostatus with relapse after acute disseminated encephalomyelitis and proposed diagnostic criteria for Mog-igg-associated disorders","volume":"75","author":"L\u00f3pez-Chiriboga","year":"2018","journal-title":"JAMA Neurol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/s1474-4422(21)00218-0","article-title":"Myelin-oligodendrocyte glycoprotein antibody-associated disease","volume":"20","author":"Marignier","year":"2021","journal-title":"Lancet Neurol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ejpn.2020.10.005","article-title":"E.U. Paediatric Mog consortium consensus: part 5 - treatment of Paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders","volume":"29","author":"Bruijstens","year":"2020","journal-title":"Eur J Paediatr Neurol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/brain\/awx276","article-title":"Clinical presentation and prognosis in Mog-antibody disease: a Uk study","volume":"140","author":"Jurynczyk","year":"2017","journal-title":"Brain"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/ana.25957","article-title":"Silent new brain Mri lesions in children with Mog-antibody associated disease","volume":"89","author":"Fadda","year":"2021","journal-title":"Ann Neurol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ejpn.2020.10.006","article-title":"E.U. Paediatric Mog consortium consensus: part 1 - classification of clinical phenotypes of Paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders","volume":"29","author":"Bruijstens","year":"2020","journal-title":"Eur J Paediatr Neurol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e200065","DOI":"10.1212\/nxi.0000000000200065","article-title":"Early immunotherapy and longer corticosteroid treatment are associated with lower risk of relapsing disease course in pediatric Mogad","volume":"10","author":"Margherita","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1471-4159.1989.tb10930.x","article-title":"Differential ultrastructural localization of myelin basic protein, myelin\/Oligodendroglial glycoprotein, and 2\u2032,3'-cyclic nucleotide 3'-phosphodiesterase in the Cns of adult rats","volume":"52","author":"Brunner","year":"1989","journal-title":"J Neurochem"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jns.2018.06.028","article-title":"The pathological features of Mog antibody-positive cerebral cortical encephalitis as a new Spectrum associated with Mog antibodies: a case report","volume":"392","author":"Ikeda","year":"2018","journal-title":"J Neurol Sci"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/jnnp-2016-315094","article-title":"Bilateral frontal cortex encephalitis and Paraparesis in a patient with anti-Mog antibodies","volume":"88","author":"Fujimori","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1537538\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T05:13:45Z","timestamp":1740546825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1537538\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":28,"alternative-id":["10.3389\/fneur.2025.1537538"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1537538","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]},"article-number":"1537538"}}